NASDAQ : HYPR
Hyperfine, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 0.7436 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 78.86M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 76.10M |
| Enterprise Value | 46.06M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 90.99M |
| Shares Outstanding | 106.05M |
| Shares Change (YoY) | +23.85% |
| Shares Change (QoQ) | +2.15% |
| Owned by Insiders (%) | 16.15% |
| Owned by Institutions (%) | 19.42% |
| Float | 86.42M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.60 |
| Forward PS | 3.29 |
| PB Ratio | 2.07 |
| P/TBV Ratio | 2.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 2.79 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 6.15 |
| Quick Ratio | 5.11 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -54.57 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -96.97% |
| Return on Assets (ROA) | -38.82% |
| Return on Invested Capital (ROIC) | -49.12% |
| Return on Capital Employed (ROCE) | -62.98% |
| Weighted Average Cost of Capital (WACC) | 10.97% |
| Revenue Per Employee | $162,127 |
| Profits Per Employee | -$341,686 |
| Employee Count | 102 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 1.38 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.46 |
| 52-Week Price Change | -38.14% |
| 50-Day Moving Average | 0.81 |
| 200-Day Moving Average | 1.13 |
| Relative Strength Index (RSI) | 38.18 |
| Average Volume (20 Days) | 1,203,873 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 3.77M |
| Short Previous Month | 3.90M |
| Short % of Shares Out | 3.56% |
| Short % of Float | 4.37% |
| Short Ratio (days to cover) | 3.29 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 16.54M |
| Gross Profit | 8.50M |
| Operating Income | -33.62M |
| Pretax Income | -34.85M |
| Net Income | -34.85M |
| EBITDA | -32.50M |
| EBIT | -33.62M |
| Loss Per Share | -$0.38 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 43.46M |
| Total Debt | 13.41M |
| Net Cash | 30.05M |
| Net Cash Per Share | $0.28 |
| Equity (Book Value) | 36.76M |
| Book Value Per Share | 0.35 |
| Working Capital | 49.61M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -27.07M |
| Capital Expenditures | -465,000 |
| Depreciation & Amortization | 1.12M |
| Net Borrowing | 13.64M |
| Free Cash Flow | -27.53M |
| FCF Per Share | -$0.26 |
Margins
| Measure | Value |
|---|
| Gross Margin | 51.41% |
| Operating Margin | -203.27% |
| Pretax Margin | -210.75% |
| Profit Margin | -210.75% |
| EBITDA Margin | -196.52% |
| EBIT Margin | -203.27% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -23.85% |
| Shareholder Yield | -23.85% |
| Earnings Yield | -52.38% |
| FCF Yield | -36.18% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $2.03 |
| Price Target Difference | 182.19% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 37.16% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -5.69 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |